{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:24:36Z","timestamp":1786929876057,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008222","name":"Universit\u00e9 de Montpellier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008222","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55708-1","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:24:28Z","timestamp":1780629868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of incident cardiovascular events in giant cell arteritis using data from a nationwide French cohort"],"prefix":"10.1038","volume":"16","author":[{"given":"B.","family":"Jauzelon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Pereira dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Roubille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dumain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Gomes de Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Granel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-4097","authenticated-orcid":false,"given":"Radjiv","family":"Goulabchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"55708_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.revmed.2017.03.007","volume":"38","author":"A Mahr","year":"2017","unstructured":"Mahr, A., Aouba, A., Richeb\u00e9, P. & Gonzalez-Chiappe, S. \u00c9pid\u00e9miologie et histoire naturelle de l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes (Horton). Rev. M\u00e9decine Interne. 38, 663\u2013669 (2017).","journal-title":"Rev. M\u00e9decine Interne"},{"key":"55708_CR2","doi-asserted-by":"publisher","first-page":"A125","DOI":"10.1016\/j.revmed.2022.03.326","volume":"43","author":"H De Boysson","year":"2022","unstructured":"De Boysson, H. et al. Incidences nationale et r\u00e9gionales de l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes en France m\u00e9tropolitaine et d\u2019Outre-mer. Rev. M\u00e9decine Interne. 43, A125\u2013A126 (2022).","journal-title":"Rev. M\u00e9decine Interne"},{"key":"55708_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5152\/eurjrheum.2024.23065","volume":"11","author":"P Estrada","year":"2024","unstructured":"Estrada, P. et al. Clinical Phenotypes of Giant Cell Arteritis: Insights into Complications and Survival Outcomes. Eur. J. Rheumatol. 11, 33\u201338 (2024).","journal-title":"Eur. J. Rheumatol."},{"key":"55708_CR4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta, J. A., Thomas, J., Sadatsafavi, M., Lehman, A. J. & Lacaille, D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann. Rheum. Dis. 71, 1524\u20131529 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"55708_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","volume":"31","author":"NN Mehta","year":"2010","unstructured":"Mehta, N. N. et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur. Heart J. 31, 1000\u20131006 (2010).","journal-title":"Eur. Heart J."},{"key":"55708_CR6","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/acr.25081","volume":"75","author":"R Goulabchand","year":"2023","unstructured":"Goulabchand, R. et al. Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study. Arthritis Care Res. 75, 1830\u20131837 (2023).","journal-title":"Arthritis Care Res."},{"key":"55708_CR7","doi-asserted-by":"publisher","unstructured":"Li, L., Neogi, T. & Jick, S. Giant cell arteritis and vascular disease\u2014risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology kew482 https:\/\/doi.org\/10.1093\/rheumatology\/kew482 (2017).","DOI":"10.1093\/rheumatology\/kew482"},{"key":"55708_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.revmed.2005.10.009","volume":"27","author":"L Le Page","year":"2006","unstructured":"Le Page, L. et al. Incidence des accidents cardiovasculaires au cours de la maladie de Horton: r\u00e9sultats pr\u00e9liminaires de l\u2019\u00e9tude prospective en double cohorte GRACG. Rev. M\u00e9decine Interne. 27, 98\u2013105 (2006).","journal-title":"Rev. M\u00e9decine Interne"},{"key":"55708_CR9","doi-asserted-by":"crossref","unstructured":"Tomasson, G. et al. Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis: (2015).","DOI":"10.7326\/L14-5015-2"},{"key":"55708_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3899\/jrheum.160249","volume":"44","author":"AJ Mohammad","year":"2017","unstructured":"Mohammad, A. J., Englund, M., Turesson, C., Tomasson, G. & Merkel, P. A. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study. J. Rheumatol. 44, 84\u201390 (2017).","journal-title":"J. Rheumatol."},{"key":"55708_CR11","doi-asserted-by":"publisher","unstructured":"Cardiovascular Risk and Acute Coronary Syndrome in Giant Cell Arteritis. A Population-Based Retrospective Cohort Study. https:\/\/doi.org\/10.1002\/acr.22416 doi:10.1002\/acr.22416.","DOI":"10.1002\/acr.22416"},{"key":"55708_CR12","doi-asserted-by":"publisher","first-page":"e0149579","DOI":"10.1371\/journal.pone.0149579","volume":"11","author":"A Lo Gullo","year":"2016","unstructured":"Lo Gullo, A. et al. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study. PLoS ONE. 11, e0149579 (2016).","journal-title":"PLoS ONE"},{"key":"55708_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.semarthrit.2014.10.010","volume":"44","author":"P Ungprasert","year":"2015","unstructured":"Ungprasert, P., Koster, M. J. & Warrington, K. J. Coronary artery disease in giant cell arteritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 44, 586\u2013591 (2015).","journal-title":"Semin Arthritis Rheum."},{"key":"55708_CR14","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.autrev.2018.06.012","volume":"17","author":"T Chazal","year":"2018","unstructured":"Chazal, T. et al. Giant-cell arteritis-related mortality in France: A multiple-cause-of-death analysis. Autoimmun. Rev. 17, 1219\u20131224 (2018).","journal-title":"Autoimmun. Rev."},{"key":"55708_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/rheumatology\/key028","volume":"57","author":"A Aouba","year":"2018","unstructured":"Aouba, A. et al. Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980\u20132011). Rheumatology 57, 1047\u20131055 (2018).","journal-title":"Rheumatology"},{"key":"55708_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin, P. C., Lee, D. S. & Fine, J. P. Introduction to the Analysis of Survival Data in the Presence of Competing Risks. Circulation 133, 601\u2013609 (2016).","journal-title":"Circulation"},{"key":"55708_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/rheumatology\/kev262","volume":"55","author":"N Amiri","year":"2016","unstructured":"Amiri, N., De Vera, M., Choi, H. K., Sayre, E. C. & Avina-Zubieta, J. A. Increased risk of cardiovascular disease in giant cell arteritis: a general population\u2013based study. Rheumatology 55, 33\u201340 (2016).","journal-title":"Rheumatology"},{"key":"55708_CR18","doi-asserted-by":"publisher","first-page":"e003960","DOI":"10.1136\/rmdopen-2023-003960","volume":"10","author":"P Stamatis","year":"2024","unstructured":"Stamatis, P. et al. Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden. RMD Open. 10, e003960 (2024).","journal-title":"RMD Open."},{"key":"55708_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.semarthrit.2016.07.005","volume":"46","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert, P., Wijarnpreecha, K., Koster, M. J., Thongprayoon, C. & Warrington, K. J. Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum. 46, 361\u2013366 (2016).","journal-title":"Semin Arthritis Rheum."},{"key":"55708_CR20","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/jcm10112299","volume":"10","author":"C Roubille","year":"2021","unstructured":"Roubille, C. et al. Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides. J. Clin. Med. 10, 2299 (2021).","journal-title":"J. Clin. Med."},{"key":"55708_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2174\/0929867327666200824112056","volume":"28","author":"A Gasmi","year":"2021","unstructured":"Gasmi, A. et al. Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors. Curr. Med. Chem. 28, 800\u2013826 (2021).","journal-title":"Curr. Med. Chem."},{"key":"55708_CR22","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/ATVBAHA.112.300276","volume":"32","author":"NN Hooten","year":"2012","unstructured":"Hooten, N. N., Ejiogu, N., Zonderman, A. B. & Evans, M. K. Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease. Arterioscler. Thromb. Vasc Biol. 32, 2776\u20132784 (2012).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"55708_CR23","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/ijms20092154","volume":"20","author":"V Mercurio","year":"2019","unstructured":"Mercurio, V. et al. Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients. Int. J. Mol. Sci. 20, 2154 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"55708_CR24","unstructured":"HAS. Protocole National de Diagnostic et de Soins - Art\u00e9rite \u00e0 cellules g\u00e9antes (Horton), r\u00e9vision Avril 2020. (2020)."},{"key":"55708_CR25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","volume":"74","author":"L Fardet","year":"2014","unstructured":"Fardet, L. & F\u00e8ve, B. Systemic Glucocorticoid Therapy: a Review of its Metabolic and Cardiovascular Adverse Events. Drugs 74, 1731\u20131745 (2014).","journal-title":"Drugs"},{"key":"55708_CR26","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1093\/rheumatology\/keaa850","volume":"60","author":"C Roubille","year":"2021","unstructured":"Roubille, C. et al. Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis. Rheumatol. Oxf. Engl. 60, 3738\u20133746 (2021).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"55708_CR27","doi-asserted-by":"publisher","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","volume":"17","author":"M Pujades-Rodriguez","year":"2020","unstructured":"Pujades-Rodriguez, M., Morgan, A. W., Cubbon, R. M. & Wu, J. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Med. 17, e1003432 (2020).","journal-title":"PLoS Med."},{"key":"55708_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40744-018-0112-8","volume":"5","author":"S Gale","year":"2018","unstructured":"Gale, S. et al. Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK. Rheumatol. Ther. 5, 327\u2013340 (2018).","journal-title":"Rheumatol. Ther."},{"key":"55708_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","volume":"54","author":"B Baslund","year":"2015","unstructured":"Baslund, B., Helleberg, M., Faurschou, M. & Obel, N. Mortality in patients with giant cell arteritis. Rheumatology 54, 139\u2013143 (2015).","journal-title":"Rheumatology"},{"key":"55708_CR30","doi-asserted-by":"publisher","first-page":"1243791","DOI":"10.3389\/fmed.2023.1243791","volume":"10","author":"LK Brekke","year":"2023","unstructured":"Brekke, L. K., Assmus, J. & Fevang, B. T. S. Factors predicting death and cancer in patients with giant cell arteritis in Western Norway 1972\u20132012: a retrospective observational cohort study. Front. Med. 10, 1243791 (2023).","journal-title":"Front. Med."},{"key":"55708_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","volume":"79","author":"L Liberale","year":"2022","unstructured":"Liberale, L. et al. Inflammation, Aging and Cardiovascular Disease: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 79, 837\u2013847 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"55708_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci, L. & Fabbri, E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 15, 505\u2013522 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"55708_CR33","doi-asserted-by":"crossref","unstructured":"Libby, P. Inflammation in atherosclerosis. 420, (2002).","DOI":"10.1038\/nature01323"},{"key":"55708_CR34","doi-asserted-by":"publisher","first-page":"843305","DOI":"10.3389\/fnagi.2022.843305","volume":"14","author":"R Watanabe","year":"2022","unstructured":"Watanabe, R. & Hashimoto, M. Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders. Front. Aging Neurosci. 14, 843305 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"55708_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.104.521708","volume":"112","author":"M Ezzati","year":"2005","unstructured":"Ezzati, M., Henley, S. J., Thun, M. J. & Lopez, A. D. Role of smoking in global and regional cardiovascular mortality. Circulation 112, 489\u2013497 (2005).","journal-title":"Circulation"},{"key":"55708_CR36","unstructured":"HAS. Protocole National de Diagnostic et de soins - Art\u00e9rite \u00e0 cellules g\u00e9antes. (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55708-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:40:48Z","timestamp":1786927248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55708-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55708"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55708-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25666"}}